In a filing, Inhibrx Biosciences Inc. revealed its Director Kayyem Jon Faiz acquired Company’s shares for reported $1.0 million on Jun 05 ’24. In the deal valued at $17.32 per share,57,549 shares were bought. As a result of this transaction, Kayyem Jon Faiz now holds 1,150,410 shares worth roughly $13.66 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Eckelman Brendan P. sold 300,000 shares, generating $10,290,000 in total proceeds. Upon selling the shares at $34.30, the Chief Scientific Officer now owns 1,735,553 shares.
Before that, VIKING GLOBAL INVESTORS LP bought 511,627 shares. Inhibrx Biosciences Inc. shares valued at $9,899,982 were divested by the 10% Owner at a price of $19.35 per share. As a result of the transaction, VIKING GLOBAL INVESTORS LP now holds 511,627 shares, worth roughly $6.07 million.
JMP Securities initiated its Inhibrx Biosciences Inc. [INBX] rating to a Mkt perform in a research note published recently.
Price Performance Review of INBX
On Tuesday, Inhibrx Biosciences Inc. [NASDAQ:INBX] saw its stock fall -4.58% to $11.87. Over the last five days, the stock has lost -16.88%. Inhibrx Biosciences Inc. shares have fallen nearly -65.21% since the year began. Nevertheless, the stocks have fallen -35.83% over the past one year. A total of 0.29 million shares were traded, compared to the trading of 0.11 million shares in the previous session.
Levels Of Support And Resistance For INBX Stock
The 24-hour chart illustrates a support level at 11.05, which if violated will result in even more drops to 10.23. On the upside, there is a resistance level at 13.28. A further resistance level may holdings at 14.69. The Relative Strength Index (RSI) on the 14-day chart is 32.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.07%. Stochastics%K at 25.25% indicates the stock is a holding.
